Inhibition of tumor IFN-γ signaling has been found to decrease IFN-stimulated genes (ISGs) in cancer cells and increase ISGs in immune cells by enhancing IFN-γ production by exhausted T cells. The gene discussed is IFNG; the disease is neoplasm.